https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Purpose To investigate the prognostic efficacy of the Geriatric Nutritional Risk Index (GNRI) in patients with metastatic Castration-resistant Prostate Cancer (mCRPC) receiving docetaxel as the first line of treatment. Methods We retrospectively reviewed patients with mCRPC and receiving first line docetaxel in Taichung Veterans General Hospital from 2006 to 2012. The GNRI was calculated using serum albumin and body mass index, with a poor nutritional status defined as GNRI less then 92.0. Multivariate Cox-regression analysis was used
Me gusta
Comentario
Compartir
